This research mainly revealed that upon interaction with p53, BMI1 epigenetically repressed transcription of miR-3682-3p, which in turn increased P-GP expression, resulting in the enhanced drug efflux and chemoresistance of bladder cancer cells. This evidence concerns the gene BMI1 and urinary bladder carcinoma.